Historical patterns indicate that abrupt fluctuations in the market can impact any firm, regardless of its seeming dominance.
Pfizer has beaten its earnings per share (EPS) estimates in its past 12 quarters. Beating EPS estimates hasn't always meant positive movements for Pfizer's share price. The stock's low valuation and ...
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results